| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Environmental Health Sciences [D. T. M., M. L. V., W. D. S.] and Medicine [M. L. V., W. D. S.], Ireland Cancer Center, University Hospitals, Case Western Reserve University, Cleveland, Ohio 44106
The mutational specificity of the alkylating agent 1-3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) was analyzed at the endogenous hemizygous adenine phosphoribosyl transferase gene of the Chinese hamster ovary cell line D422. A 1-h treatment of the Chinese hamster ovary cells with 50 µM BCNU resulted in a toxicity level of 62% and induced mutation at this target with a frequency of 32.1 mutants/106 survivors (6-fold above background). Analysis of 49 BCNU-induced mutants at the DNA sequence level revealed that BCNU induced primarily base substitutions. The predominant BCNU-induced mutations were G:C
T:A transversions, which comprised 51% (25 of 49) of the mutations; while G:C
A:T transitions, expected from miscoding of O6-alkylguanine, represented only 16.3% (8 of 49) of the mutants recovered. This result was not anticipated, since Chinese hamster ovary cells are deficient in O6-alkylguanine-DNA alkyltransferase, which should render them especially sensitive to O6-alkylguanine-mediated mutations. It was also notable that two "hotspots" for BCNU-induced G:C
T:A transversions were observed, which involved different surrounding DNA sequences but similar helix parameters when analyzed by an application of Calladine's Rules. Possible mechanisms for the observed BCNU-induced mutations are presented.
1 Supported in part by National Institute of Environmental Health Services Research Grant R01 ESO5540 awarded to W. D. S.; a research grant from the Cuyahoga County Unit, Ohio Division of the American Cancer Society, awarded to M. L. V.; a research grant from Glaxo, Inc., to W. D. S. and M. L. V.; and a Cancer Center core grant to the Ireland Cancer Center (P30CA43703).
2 To whom requests for reprints should be addressed, at Case Western Reserve University, Department of Medicine, Hematology/Oncology, UCRC Building 2, Suite 200, 11001 Cedar Road, Cleveland, OH 44106.
Received 2/17/92. Accepted 6/17/92.
This article has been cited by other articles:
![]() |
M. D. Bacolod, S. P. Johnson, A. E. Pegg, M. E. Dolan, R. C. Moschel, N. S. Bullock, Q. Fang, O. M. Colvin, P. Modrich, D. D. Bigner, et al. Brain tumor cell lines resistant to O6-benzylguanine/1,3-bis(2-chloroethyl)-1-nitrosourea chemotherapy have O6-alkylguanine-DNA alkyltransferase mutations Mol. Cancer Ther., September 1, 2004; 3(9): 1127 - 1135. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Bacolod, S. P. Johnson, F. Ali-Osman, P. Modrich, N. S. Bullock, O. M. Colvin, D. D. Bigner, and H. S. Friedman Mechanisms of Resistance to 1,3-Bis(2-chloroethyl)-1-nitrosourea in Human Medulloblastoma and Rhabdomyosarcoma Mol. Cancer Ther., July 1, 2002; 1(9): 727 - 736. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Inga, F.-X. Chen, P. Monti, A. Aprile, P. Campomenosi, P. Menichini, L. Ottaggio, S. Viaggi, A. Abbondandolo, B. Gold, et al. N-(2-Chloroethyl)-N-nitrosourea Tethered to Lexitropsin Induces Minor Groove Lesions at the p53 cDNA That Are More Cytotoxic than Mutagenic Cancer Res., February 1, 1999; 59(3): 689 - 695. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |